Amgen to Build Generative AI Models for Novel Human Data Insights and Drug Discovery

	Amgen to Build Generative AI Models for Novel...

Generative AI is transforming drug research and development, enabling new discoveries faster than ever — and Amgen, one of the world’s leading biotechnology companies, is tapping the technology to power its research. Amgen will build AI models trained to analyze one of the world’s largest human datasets on an NVIDIA DGX SuperPOD, a full-stack data Read article >

- View Press Release
- Visit NVIDIA Corporation

Posted: January 8, 2024 | By: Wissen Schwamm

Recent NVIDIA related news.

Explainable AI: Insights from Arthur’s Adam Wenchel

Say It Again: ChatRTX Adds New AI Models, Features in Latest Update

AI Takes a Bow: Interactive GLaDOS Robot Among 9 Winners in Hackster.io Challenge

SEA.AI Navigates the Future With AI at the Helm

AI Drives Future of Transportation at Asia’s Largest Automotive Show

+ View more NVIDIA related news +

			More Technical Information Than You Can Handle.

Amgen to Build Generative AI Models for Novel...